• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“风险区域”严重程度对心肌梗死面积治疗干预的影响。

Effect of severity of "risk region" on therapeutic intervention of myocardial infarction size.

作者信息

Mukherjee D

机构信息

N.R.S. Medical College, Calcutta.

出版信息

Indian J Pathol Microbiol. 1992 Jul;35(3):241-6.

PMID:1344159
Abstract

Isosorbide dinitrate was tried in 27 patients of acute myocardial infarction (AMI) with the purpose of reduction of infarction size. Overall average effect was not significant. But, it was found that, the small and moderate "predicted infarction size" (PIS) group of patients, were benefitted by the drug therapy. Effectiveness in the therapeutic intervention on ischaemic injury bore an inverse relation with the degree of PIS or the "risk region". Varying "risk region" may be an important factor responsible for the apparent discrepancy between results of different workers regarding therapeutic intervention of infarction size.

摘要

对27例急性心肌梗死(AMI)患者试用了硝酸异山梨酯,目的是缩小梗死面积。总体平均效果不显著。但是,发现小面积和中等面积“预测梗死面积”(PIS)组的患者从药物治疗中获益。对缺血性损伤的治疗干预效果与PIS程度或“危险区域”呈负相关。不同的“危险区域”可能是不同研究者在梗死面积治疗干预结果方面存在明显差异的一个重要因素。

相似文献

1
Effect of severity of "risk region" on therapeutic intervention of myocardial infarction size.“风险区域”严重程度对心肌梗死面积治疗干预的影响。
Indian J Pathol Microbiol. 1992 Jul;35(3):241-6.
2
Effect of isosorbide dinitrate on enzymatically estimated infarction size and on clinical condition of the patients of acute myocardial infarction.硝酸异山梨酯对急性心肌梗死患者酶学估算梗死面积及临床状况的影响。
Indian J Pathol Microbiol. 1990 Apr;33(2):144-50.
3
Importance of peak enzyme level and reinfarction while attempting to intervene myocardial infarction process.在试图干预心肌梗死过程中,峰值酶水平和再梗死的重要性。
J Indian Med Assoc. 1989 Oct;87(10):229-31.
4
[Drug therapy of acute myocardial infarction without cardiogenic shock and thrombolytic therapy excluded].
Arch Mal Coeur Vaiss. 1992 May;85(5 Suppl):763-71.
5
[Value of isosorbide dinitrate injection in the acute phase of myocardial infarction. Clinical and haemodynamic study (author's transl)].硝酸异山梨酯注射液在心肌梗死急性期的价值。临床与血液动力学研究(作者译)
Nouv Presse Med. 1982 Jun 10;11(27):2075-7.
6
Haemodynamic assessment of isosorbide dinitrate (sorbitrate) therapy in cases of acute myocardial infarction.急性心肌梗死病例中硝酸异山梨酯(消心痛)治疗的血流动力学评估
Indian Heart J. 1980 Sep-Oct;32(5):303-7.
7
Oral ISDN for the treatment of patients with acute myocardial infarction.
Z Kardiol. 1983;72 Suppl 3:147-51.
8
[Use of isosorbide dinitrate (Risordan) injection in left ventricular failure following acute myocardial infarction (author's transl)].
Nouv Presse Med. 1982 Jun 10;11(27):2079-82.
9
[Treatment with isosorbide dinitrate of chronic myocardial infarction depending on the results of floating catheter-ergometer loading].
Med Welt. 1980 Oct 10;31(41):1485-90.
10
[Isosorbide dinitrate treatment of silent myocardial ischemia in patients after myocardial infarction].[硝酸异山梨酯治疗心肌梗死后患者的无症状心肌缺血]
Przegl Lek. 1989;46(3):350-5.